Hua Zhou

机构：Guangzhou University of Chinese Medicine, Merck & Co., Inc., Rahway, NJ, USA (United States), Ministry of Education of the People's Republic of China, Shanxi Medical University, Peking University, Ji Hua Laboratory, Ganzhou People's Hospital, Fourth People’s Hospital of Jinan, Second Hospital of Shanxi Medical University, Peking University Third Hospital · ORCID：0000-0001-6508-7942

发表论文 310 篇 · 总被引 4133 次 · h-index 35

代表论文

• Effects of the DPP-1 inhibitor HSK31858 in adults with bronchiectasis in China (SAVE-BE): a phase 2, multicentre, double-blind, randomised, placebo-controlled trial (2025 · The Lancet Respiratory Medicine · 被引 40)
• The Landscape of lower respiratory tract herpesviruses in severe pneumonia patients: a multicenter, retrospective study with prospective validation (2025 · Critical Care · 被引 15)
• Total glucosides of paeony ameliorates lupus nephritis by suppressing ZBP1-mediated PANoptosis in podocytes (2025 · Phytomedicine · 被引 12)
• B cell and anti-PLA2R antibody-guided rituximab therapy in idiopathic membranous nephropathy: a prospective multi-center cohort study in the East Coastal Region of China (2025 · Frontiers in Immunology · 被引 2)
• Corrigendum to “A novel quantification method of lung fibrosis based on Micro-CT images developed with the optimized pulmonary fibrosis mice model induced by bleomycin” [Heliyon Volume 9, Issue 3, March 2023, Article e13598] (2025 · Heliyon · 被引 2)
• Systemic inflammatory biomarkers as mediators of the association between dietary flavonoids and sleep disorders in patients with hypertension: A population-based study (2025 · Journal of Functional Foods · 被引 2)